Previous Article | Next Article 
Journal of Clinical Microbiology, September 2000, p. 3375-3378, Vol. 38, No. 9
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cutaneous Infection Caused by Cylindrocarpon
lichenicola in a Patient with Acute Myelogenous Leukemia
Peter C.
Iwen,1,*
Stefano R.
Tarantolo,2
Deanna A.
Sutton,3
Michael G.
Rinaldi,3,4 and
Steven H.
Hinrichs1
Departments of Pathology and
Microbiology1 and Internal
Medicine,2 University of Nebraska Medical
Center, Omaha, Nebraska, and Fungus Testing Laboratory,
Department of Pathology, University of Texas Health Science Center
at San Antonio,3 and Audie L. Murphy
Division, South Texas Veterans Health Care
System,4 San Antonio, Texas
Received 17 April 2000/Returned for modification 10 May
2000/Accepted 30 June 2000
 |
ABSTRACT |
Cylindrocarpon lichenicola is a saprophytic soil fungus
which has rarely been associated with human disease. We report the first case of localized invasive cutaneous infection caused by this
fungus in a 53-year-old male from the rural midwestern United States
with relapsed acute myelogenous leukemia. On admission for induction
chemotherapy, the patient was noted to have an abrasive laceration
between the fourth and fifth metacarpophalangeal joints and on the
dorsum of the right hand, which progressed to frank ulceration
following chemotherapy. A biopsy provided an initial diagnosis of an
invasive fungal infection consistent with aspergillosis based on the
histopathological appearance of the mold in tissue. Multiple positive
fungal cultures which were obtained from the biopsied tissue were
subsequently identified by microscopic and macroscopic characteristics
to be C. lichenicola. The infection resolved following
marrow regeneration, aggressive debridement of the affected tissue, and
treatment with amphotericin B. This case extends the conditions
associated with invasive disease caused by C. lichenicola.
 |
INTRODUCTION |
Cylindrocarpon species
are soil fungi which are rarely associated with human disease. These
species have been characterized as causes of keratitis (2),
mycetoma (20), athlete's foot (12), peritonitis
(18), and more recently, disseminated infection in a
neutropenic patient (11). This report describes a case of
invasive infection localized to the right hand caused by
Cylindrocarpon lichenicola in a patient with acute
myelogenous leukemia (AML) following rural exposure and expands the
clinical entities associated with this mold.
(This work was presented in part at the 9th Focus on Fungal Infections,
San Diego, Calif., May 1999.)
 |
CASE REPORT |
A 53-year-old male social worker who was also a farm
hobbyist with a history of polycythemia vera presented with fever and extreme fatigue. Review of the peripheral blood smear showed 70% circulating blasts, consistent with AML (FAB-M2). On admission for
induction chemotherapy, the patient was noted to have an abrasive laceration between the fourth and fifth metacarpophalangeal joints and
on the dorsum of the right hand, which he stated happened "while
herding pigs." Cultures of the hand were negative for bacterial pathogens, and Polysporin ointment (Burroughs Wellcome, Research Triangle Park, N.C.) was applied to the cutaneous lesions. He required
two cycles of induction chemotherapy with idarubicin and cytarabine to
achieve a remission. Filgastrum was started 24 h after the last
dose of chemotherapy. Three days after completion of chemotherapy, the
laceration on the right hand had progressed to frank ulceration, and
the orthopedic staff were consulted for possible debridement. A plain X
ray of the right hand showed no evidence of osteomyelitis. A punch
biopsy of the right hand revealed numerous septate branching hyphae
that the pathologist considered consistent with Aspergillus
species (Fig. 1). Based on a diagnosis of
an invasive mold infection, intravenous amphotericin B (AmB) was
started at a dose of 0.75 mg per kg of body weight per day. Culture
from the biopsy material subsequently grew a white mold that was
identified as C. lichenicola. Removal of infected tissue when disease is localized is considered standard treatment at our
institution for patients with a hematological malignancy undergoing high-dose chemotherapy. Since the skin lesion was too large for surgical debridement, an amputation was performed, with removal of the
fourth and fifth digits and part of the palm of the right hand two days
after AmB therapy was started. Fungal cultures of tissues removed from
the lesion also grew C. lichenicola. The patient was
discharged 29 days after admission for induction chemotherapy, in
stable condition with an absolute neutrophil count of 1,360 cells per
µl. AmB therapy was continued daily in the outpatient clinic for 6 weeks, and itraconazole (Itr) was additionally prescribed (200 mg per
day) for long-term maintenance. He subsequently relapsed with AML and
successfully underwent reinduction chemotherapy without reactivation of
the invasive fungal infection. During reinduction, a pulmonary nodule
was noted on a chest X ray which was resected using a video-assisted
thoracoscopy procedure. No evidence of a mold infection following
histopathological examination of this lung tissue was noted.

View larger version (134K):
[in this window]
[in a new window]
|
FIG. 1.
Methenamine silver stain of skin tissue showing hyphal
elements and globular structures that resemble conidia. Magnification,
×580.
|
|
 |
MATERIALS AND METHODS |
Mycology.
The tissue isolate was forwarded to the
Fungus Testing Laboratory, Department of Pathology, University of Texas
Health Science Center (UTHSC) at San Antonio, for characterization and
susceptibility testing. It was entered into the UTHSC stock collection
under accession number UTHSC 98-2175. To induce conidiation, the
isolate was subcultured onto potato flakes agar (PFA) plates (prepared in-house) (15) and PFA slide cultures, both incubated at
25°C. The microscopic morphology was examined from colonies on PFA
plates and slide culture mounts after 6 days of incubation. Temperature studies were performed on PFA slants to evaluate the growth rate at 25, 35, and 42°C. A subculture of the case isolate was deposited in the
American Type Culture Collection (ATCC) under accession number ATCC 204306.
Antifungal susceptibility testing.
Susceptibility testing
was performed on the case isolate by utilizing the National Committee
for Clinical Laboratory Standards Macrobroth Dilution Method M27-A,
modified for mold testing (13). Briefly, the case isolate
and the Paecilomyces control strain (UTHSC 90-459) were
grown on PFA for 7 days at 25°C and the inocula were standardized
spectrophotometrically. The PFA slants were overlaid with sterile
distilled water, and suspensions were made by gently scraping the
colonies with the tip of a Pasteur pipette. Heavy hyphal fragments were
allowed to settle, and the upper, homogenous suspensions were removed.
Suspensions were adjusted to a 95% transmission at 530 nm and then
diluted 1:10 in medium to provide a 1.0 × 104
inoculum concentration as determined by plate counts. Final drug concentration ranges were as follows: AmB (E. R. Squibb & Sons, Princeton, N.J.), 0.03 to 16 µg/ml; 5-fluorocytosine (5-Fc; Roche Laboratories, Nutley, N.J.), 0.125 to 64 µg/ml; and Itr, (Janssen Pharmaceutica, Titusville, N.J.), 0.015 to 8 µg/ml. AmB was tested in
Antibiotic Medium 3 (Difco, Detroit, Mich.); other antifungal agents
were tested in RPMI 1640 with L-glutamine and
morpholinepropanesulfonic acid (MOPS) buffer at a concentration of 165 mM and without sodium bicarbonate (American Biorganics, Inc., Niagara
Falls, N.Y.). Previously prepared, frozen drug tubes containing 0.1 ml
of drug were allowed to thaw and were inoculated with 0.9 ml of the
hyphal medium suspension. The tubes were incubated at 35°C, and MICs were read at the first 24-h interval when growth was observed in the
drug-free growth control. MICs were defined as the first tube that
yielded a score of 0 (optically clear) for AmB and a score of 2 (reduction in turbidity that was equal to or greater than 80% of the
turbidity of the drug-free control tube) for 5-Fc and Itr. Minimum
lethal concentrations (MLCs) for AmB were determined by plating
100-µl samples onto Sabouraud dextrose agar (SBA) plates from tubes
containing the following: drug-free control, AmB at the MIC, and AmB at
concentrations above the MIC, all incubated at 35°C. The MLC was
defined as the lowest concentration of antifungal compound resulting in
five or fewer colonies on the SBA plate, which represented 99.9%
killing (16).
Molecular testing.
The complete internal transcribed spacer
(ITS) 1 region, 5.8S rDNA region, and the ITS 2 region of C. lichenicola was amplified and sequenced using a previously
described procedure (9). Comparison of the case isolate
sequence to GenBank database sequences was performed using a
non-gapped, advanced BLAST search. The similarities to other sequences
was determined with the expectation frequency minimized to 0.0001. Sequences were not filtered for low complexity.
Nucleotide sequence accession number.
The nucleotide
sequence for C. lichenicola of this region was deposited
into the National Center for Biotechnology Information (NCBI) GenBank
database under accession no. AF133843.
 |
RESULTS |
The case isolate was identified as C. lichenicola (C. Massal, D. Hawksworth) based upon macroscopic and
microscopic features (1). Colonies on PFA exhibited rapid
growth, attaining a diameter of approximately 35 mm in 6 days at
25°C. The colonies were velvety to floccose, initially white, later
yellowing and becoming pale brown at maturity (Fig.
2). The reverse ranged from buff at the periphery to a darker brown centrally, with a brown diffusing pigment.
Hyphae were septate and hyaline, and the conidiophores were long and
simple or poorly branched (Fig. 3).
Subulate (slender and tapering to a point) conidiogenous cells
(phialides) were 38 by 50 µm in length and 3 by 5 µm in diameter
and sometimes had a distinct collarette at the apices. Macroconidia
were borne singly and in clusters at the apices of phialides (Fig.
4). They were smooth, hyaline, rounded at
the tip, distinctly truncate at the base with offset basal pedicels
(17), predominately 3-septate but occasionally up to
5-septate, and ranged from 19.6 to 32 µm long by 5 µm wide (Fig.
5) (4). Septations appeared as
rings around the macroconidia. In old cultures, chlamydoconidia formed and in face view appeared as distinct globose cells within the multicellular macroconidia (Fig. 6).
Microconidia were absent. Numerous chlamydoconidia also were produced
after 2 weeks of incubation from terminal or short lateral branches. In
older cultures, chlamydoconidia were globose, hyaline to pale brown,
smooth to spinulose, 8 to 15 µm in diameter, and occurred singly
(Fig. 3), in clusters (Fig. 3 and 6), and in short chains. Temperature
studies revealed poor growth at 35°C and no growth at 42°C.

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 3.
Long, simple conidiophore, macroconidia, and clusters of
chlamydoconidia of C. lichenicola. Magnification, ×460.
|
|

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 4.
Clusters of macroconidia at the apices of long phialides
and single-cell chlamydoconidia of C. lichenicola.
Magnification, ×460.
|
|

View larger version (130K):
[in this window]
[in a new window]
|
FIG. 5.
Macroconidia of C. lichenicola with rounded
apical cells and truncate, offset basal cells. Magnification, ×920.
|
|

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 6.
Chlamydoconidia and macroconidia of C. lichenicola. Note also conidial chlamydoconidia within the
macroconidia. Magnification, ×460.
|
|
The drug susceptibility data for the case isolate showed the MICs to be
2 µg per ml for AmB at 24 and 48 h, >64 µg per ml for 5-Fc at
24 h, and >8 µg per ml for Itr at 24 h. MLCs for AmB remained at 2 µg per ml at 48 h (16). As interpreted
by these in vitro data, the isolate appeared resistant to all agents
tested based upon standard dosing regimens.
The resulting nucleotide base sequence of the ITS 1-5.8S-ITS 2 region
of the case isolate did not align with any of the known sequences
following a BLAST search within the NCBI GenBank database. No
nucleotide sequences of this target region are available from other
strains of C. lichenicola for comparison.
 |
DISCUSSION |
The genus Cylindrocarpon was described in a
monograph by Booth as containing 27 species and six varieties arranged
into four groups depending upon the presence or absence of
chlamydoconidia and microconidia (1). All species produce
slimy macroconidia in basipetal succession (the youngest conidium at
the base) which do not adhere in chains. Of these species, only
Cylindrocarpon destructans, C. lichenicola, and
Cylindrocarpon vaginae have been implicated as causes of
human disease, with C. lichenicola the only species
described in the literature as causing invasive infection (2, 11,
12, 18, 20). C. lichenicola (C. Massal, D. Hawskworth), previously known as Cylindrocarpon tonkinense
Bugnicourt, has a wide geographic distribution. Although it appears
somewhat uncommonly in temperate regions, it occurs frequently in
tropical climates, having a wide host range for woody and herbaceous
plants and being a common agent of postharvest fruit invasion
(6). The present study describes the first case of localized
cutaneous invasive disease caused by C. lichenicola
following trauma in a patient with AML recently undergoing chemotherapy.
Our patient's infection was evident upon admission to the hospital 7 days after trauma to the hand. Bacterial cultures were tested at the
time of admission, and no pathogen was identified. Fungal cultures were
not tested at this time. At the time of admission, the patient was
neutropenic with acute granulocytopenia and leukemia. Three days
following completion of two rounds of chemotherapy, it was noted that
the abrasive laceration on the right hand had progressed and a biopsy
was taken. The histological appearance of the fungus in the skin tissue
was suggestive of an Aspergillus or Fusarium
species, with an identification of either genus indicating a grave
prognosis in an immunocompromised patient (3, 10). Along
with septate branching hyphae, large globular structures mostly
associated with the hyphae were also noted in the tissue (Fig. 1). This
was inconsistent with the typical findings observed in tissue
infections with the aspergilli and fusarial species, even though under
some conditions it is not unusual for the Aspergillus species to exhibit atypical morphological features in histopathological sections (5). A retrospective reexamination of the tissue
suggested that the globular structures may have been associated
conidia, since they were similar in size (8 to 11 µm in diameter) and
shape to the conidia formed in culture. Invasive molds rarely produce conidia in tissues, and then only in lesions exposed to ambient air,
such as in a pulmonary aspergillosis fungus ball or primary cutaneous
aspergillosis in burned patients (5). In our case, the
presence of the fungus on the cutaneous surface, and therefore exposure
to ambient air, may have allowed the Cylindrocarpon
organisms to produce conidial structures.
Five days after culture of the tissue, a mold which had both cultural
and microscopic characteristics resembling a Fusarium species was detected. To further characterize the isolate and for
susceptibility testing, the isolate was submitted to a reference laboratory, where the identification of C. lichenicola was
made. It had been reported that Cylindrocarpon species
appear closely related morphologically and taxonomically to
Fusarium species, with both sharing teleomorphs in the genus
Nectria (11, 17). Because of morphological
similarities, separation of these two genera by cultural
characteristics becomes problematic at times (8). C. lichenicola most closely resembles Fusarium solani, a
common agent of keratomycoses and disseminated disease in neutropenic and/or immunocompromised hosts. The isolate differed macroscopically from F. solani by forming macroconidia which were
predominately straight rather than curved, by having apical cells that
were rounded rather than tapering, by having basal cells with truncate and offset rather than attenuated pedicels (foot cells), by lacking microconidia, by having pigmented chlamydoconidia, and by the formation
of a brown rather than cream-colored colony on PFA (Fig. 3 to 6)
(6).
Molecular methods have been suggested as a means to identify fungal
pathogens (9). Amplification and sequencing of the ITS
1-5.8S-ITS 2 region was successful; however, no other examples of this
sequence from other strains of C. lichenicola were available for comparison. This case strain represents the first sequence from
this region deposited into the NCBI GenBank. Sequencing of other
strains of this species are needed to verify intraspecies and
interspecies variations within the targeted sequence.
In a previous case of disseminated infection caused by C. lichenicola, James et al. reported clinical improvement of disease following marrow regeneration and treatment with 1 mg of AmB per kg
(11). In this reported case, the isolate demonstrated
susceptibility to AmB (MIC <0.25 µg per ml) and resistance to Itr
using an antifungal susceptibility test described by Warnock
(19). In our present patient's case per standard protocol
in our institution, extensive debridement of the area occurred 2 days
after the start of AmB therapy. Susceptibility data for the present
case suggested that the isolate was resistant to both AmB and Itr. In
both the reported case and the present case of invasive disease caused
by C. lichenicola, the patient cleared the infection;
however, it appears from both cases that the role of antifungal therapy
in the overall clinical response of these patients was unclear, since
recovery of the marrow was a critical part of the patient's condition
(7). Additionally, in our present case, prompt surgical
debridement of the isolated lesion on the right hand was a major part
of the patient's management.
The identification of a localized invasive cutaneous infection caused
by C. lichenicola in a patient from a rural area with leukemia suggested that immunosuppressed patients must be appropriately educated as to the risks gardening or farming may engender. This case
also reemphasizes the need for more rapid diagnostic tests to properly
identify fungal pathogens and a requirement for reliable antifungal
susceptibility testing so that patients with invasive mold infections
may be treated in the most efficacious method possible.
 |
ACKNOWLEDGMENTS |
We thank Mary Parsons and Delinda Sundsboe of the Clinical
Microbiology Laboratory for their continued support in the laboratory evaluation of isolates from patients with unusual fungal pathogens.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology and Microbiology, University of Nebraska Medical Center,
986495 Nebraska Medical Center, Omaha, NE 68198-6495. Phone: (402)
559-7774. Fax: (402) 559-4077. E-mail: piwen{at}unmc.edu.
 |
REFERENCES |
| 1.
|
Booth, C.
1996.
The genus Cylindrocarpon. Mycological papers, no. 104.
Commonwealth Mycological Institute, Kew, Surrey, England.
|
| 2.
|
Booth, C.,
C. Y. Clayton, and M. Usherwood.
1984.
Cylindrocarpon species associated with mycotic keratitis.
Proc. Indian Acad. Sci. Plant Sci.
94:422-436.
|
| 3.
|
Boutati, E. I., and E. J. Anaissie.
1997.
Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.
Blood
90:999-1008[Abstract/Free Full Text].
|
| 4.
|
Brayford, D.
1987.
CMI descriptions of pathogenic fungi and bacteria no. 926. Cylindrocarpon lichenicola.
Mycopathologia
100:125-126.
|
| 5.
|
Chandler, F. W., and J. C. Watts.
1987.
Aspergillosis, p. 55-74.
In
ASCP Press (ed.), Pathologic diagnosis of fungal infections, 1st ed. American Society of Clinical Pathologists, Chicago, Ill.
|
| 6.
|
de Hoog, G. S., and J. Guarro.
1995.
Atlas of clinical fungi.
Centraalbureau voor Schimmelcultures, Baarn, The Netherlands.
|
| 7.
|
Graybill, J. R.
1998.
Itraconazole: managing mycotic complications in immunocompromised patients.
Semin. Oncol.
25:58-63[Medline].
|
| 8.
|
Guarro, J., and J. Genee.
1992.
Fusarium infections. Criteria for the identification of the responsible species.
Mycoses
35:109-114[Medline].
|
| 9.
|
Henry, T.,
P. C. Iwen, and S. H. Hinrichs.
2000.
Identification of Aspergillus species using internal transcribed spacer regions 1 and 2.
J. Clin. Microbiol.
38:1510-1515[Abstract/Free Full Text].
|
| 10.
|
Iwen, P. C.,
M. E. Rupp,
M. R. Bishop,
M. G. Rinaldi,
D. A. Sutton,
S. Tarantolo, and S. H. Hinrichs.
1998.
Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation.
J. Clin. Microbiol.
36:3713-3717[Abstract/Free Full Text].
|
| 11.
|
James, E. A.,
K. Orchard,
P. H. McWhinney,
D. W. Warnock,
E. M. Johnson,
A. B. Mehta, and C. C. Kibbler.
1997.
Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemia.
J. Infect.
34:65-67[CrossRef][Medline].
|
| 12.
|
Laney, B.,
C. Blanc, and J. Lapalu.
1985.
Cylindrocarpon: a new athlete's foot agent.
Bull. Soc. Fr. Mycol. Med.
14:73-76.
|
| 13.
|
National Committee for Clinical Laboratory Standards.
1997.
Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 14.
|
Nelson, P. E.,
M. C. Dignani, and E. J. Anaissie.
1994.
Taxonomy, biology, and clinical aspects of Fusarium species.
Clin. Microbiol. Rev.
7:479-504[Abstract/Free Full Text].
|
| 15.
|
Rinaldi, M. G.
1982.
Use of potato flakes agar in clinical mycology.
J. Clin. Microbiol.
15:1159-1160[Abstract/Free Full Text].
|
| 16.
|
Rinaldi, M. G., and A. W. Howell.
1988.
Antifungal antimicrobics: laboratory evaluation, p. 325-356.
In
B. Wentworth (ed.), Diagnostic procedures for mycotic and parasitic infections, 7th ed. American Public Health Association, Washington, D.C.
|
| 17.
|
Samuels, G. J., and D. Brayford.
1993.
Phragmosporous Nectria species with Cylindrocarpon anamorphs.
Sydowia
45:55-80.
|
| 18.
|
Sharma, R.,
C. K. Farmer,
W. R. Gransden, and C. S. Ogg.
1998.
Peritonitis in continuous ambulatory peritoneal dialysis due to Cylindrocarpon lichenicola infection.
Nephrol. Dial. Transplant.
13:2662-2664[Abstract/Free Full Text].
|
| 19.
|
Warnock, D. W.
1989.
Medical mycology: a practical approach.
In
E. G. V. Evans, and M. D. Richardson (ed.), Methods with antifungal drugs. IRL Press, Oxford, United Kingdom.
|
| 20.
|
Zoutman, D. E., and L. Sigler.
1991.
Mycetoma of the foot caused by Cylindrocarpon destructans.
J. Clin. Microbiol.
29:1855-1859[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, September 2000, p. 3375-3378, Vol. 38, No. 9
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Summerbell, R. C., Schroers, H.-J.
(2002). Analysis of Phylogenetic Relationship of Cylindrocarpon lichenicola and Acremonium falciforme to the Fusarium solani Species Complex and a Review of Similarities in the Spectrum of Opportunistic Infections Caused by These Fungi. J. Clin. Microbiol.
40: 2866-2875
[Abstract]
[Full Text]